Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis

Synapse

Volumn 22, Issue 4, 1996, Pages 304-312

  Nishijima, Koichi ^a   Kashiwa, Atsushi ^a   Hashimoto, Atsushi ^a   Iwama, Hisayuki ^a   Umino, Asami ^a   Nishikawa, Toru ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Dopamine reuptake inhibition; N methyl D aspartate receptor; Tetrodotoxin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE RECEPTOR; METHAMPHETAMINE; PHENCYCLIDINE; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; FRONTAL CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; MALE; METHAMPHETAMINE; PHENCYCLIDINE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 0029916626     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199604)22:4<304::AID-SYN2>3.0.CO;2-F     Document Type: Article

References (50)

1. Bagchi, S-P. (1981) Effects of phencyclidine on synaptosomal dopamine continuously appearing from phenylalamine: Sensitivity to reserpine. Neuropharmacology, 20:845-851.
2. Bjorklund, A., and Lindvall, O. (1984) Dopamine-containing systems in the CNS. In: Classical Transmitters in the CNS, Part 1. A. Björklund and T. Hökfelt, eds. Elsevier, Amsterdam, pp. 55-122.
3. Bowers, M.B., and Hoffman, F.J. (1984) Homovanillic acid in rat caudate and prefrontal cortex following phencyclidine and amphetamine. Psychopharmacology (Berlin), 84:136-137.
4. Bowers, M.B., and Morton, J.B. (1992) Diazepam antagonizes effects on dopamine metabolism produced by PCP receptor agonists. Prog. Neuropsychopharmacol. Biol. Psychiatry, 16:211-210.
5. Bowyer, J.E., Spuhler, K.P., and Weiner, N. (1984) Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes. J. Pharmacol. Exp. Ther., 229:671-680.
6. Carboni, E., Imperato, A., Perezzani, L., and Di Chiara, G. (1989) Amiphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience, 28:653-661.
7. Deutch, A.Y., Tam, S.-Y., Freeman, A.S., Bowers, Jr., M.B.B., and Roth, R.H. (1987) Mesolimbic and mesocortical dopamine activation induced by phencyclidine: Contrasting pattern to striatal response. Eur. J. Pharmacol., 134:257-264.
8. Freeman, A.S., and Bunney, B.S. (1984) The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur. J. Pharmacol., 104:287-293.
9. French, E.D., Mura, A., and Wang, T. (1993) MK-801, phencyclidine (PCP) and PCP-like drugs increase burst firing in rat AlO dopamine neurons: Comparison to competitive NMDA antagonists. Synapse, 13:108-116.
10. Garey, R.E., and Heath, R.G. (1976) The effects of phencyclidine on the uptake of 3H-catecholamines by rat striatal and hypothalamic synaptosomes. Life Sci., 18:1105-1110.
11. Groves, P.M., and Tepper, J.M. (1983) Neuronal mechanisms of action of amphetamine. In: Stimulants: Neurochemical, Behavioral, and Clinical Perspectives. I. Creese, ed. Raven Press, New York, pp. 81-129.
12. Hata, N., Nishikawa, T., Umino, A., and Takahashi, K. (1990) Evidence for involvement of N-methyl-D-aspartate receptor in tonic inhibitory control of dopaminergic transmission in rat medial frontal cortex. Neurosci. Lett., 120:101-104.
13. 2H-dopamine in rat brain tissue slices. Biochem. Pharmacol., 24:847-852.
14. Hjörth, S., and Sharp, T. (1991) Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo dialysis. Life Sci., 48:1779-1786.
15. Hondo, H., Yonezawa, Y., Nakahara, T., Nakamura, K., Hirano, M., Uchmura, H., and Tashiro, N. (1994) Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Res., 633:337-342.
16. Imperato, A., and Chiara, G.D. (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: A new method for the study of the in vivo release of endogenous dopamine release and metabolites. J. Neurosci., 4:966-977.
17. Imperato, A., and Chiara, G.D. (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by transstriatal dialysis. J. Neurosci., 5:297-306.
18. Imperato, A., Scrocco, M.G., Bacci, S., and Angelucci, L. (1990) NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol., 187:555-556.
19. Javitt, D.C., and Zukin, S.R. (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry, 148:1301-1308.
20. Johnson, J.W., and Jones, S.M. (1990) Neuropharmacology of phencyclidine: Basic mechanisms and therapeutic potential. Annu. Rev. Pharmacol. Toxicol., 30:707-750.
21. Kalivas, P.W., Duffy, P., and Barrow, J (1989) Regulation of the meso-corticolimbic dopamine system by glutamic acid receptor subtypes. J. Pharmacol. Exp. Ther., 251:378-387.
22. Kashiwa. A., Nishikawa, T., Nishijima, K., Umino, A., and Takahashi, K. (1995) Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex. Neurochem. Int., 26:269-279.
23. Kemp, J.A., Foster, A.C., and Wong, E.H.F. (1987) Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci., 10:294-298.
24. Kuczenski, R. (1983) Biochemical actions of amphetamine and other stimulants. In: Stimulants: Neurochemical, Behavioral, and Clinical Perspective. I. Creese, ed. Raven Press, New York, pp. 31-61.
25. Kuczenski, R., Segal, D.S., and Aizensteina, M.L. (1991) Amphetamine, cocaine, and fencamfamine: Relationship between locomotor and stereotype response profiles and caudate and accumbens dopamine dynamics. J. Neurosci., 11:2703-2712.
26. Lehmann, J., Hutchison, A.J., McPherson, S.E., Mondadori, C., Schmutz, M., Sinton, C.M., Tsai, C., Murphy, D.E., Steel, D.J., Williams, M., Cheney, D.L., and Wood, P.L. (1988) CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. J. Pharmacol. Exp. Ther., 246:65-75.
27. Le Moal, M., and Simon, H. (1991) Mesocorticolimbic dopaminergic network: Functional and regulatory roles. Physiol. Rev., 71:155-210.
28. Lillrank, S.M., O'Connor, W.T., Oja, S.S., and Ungerstedt, U. (1994) Systemic phencyclidine administration is associated with increased dopamine, GABA, and 5-HIAA levels in the dorsolateral striatum of conscious rats: An in vivo microdialysis study. J. Neural Transm., 95:145-155.
29. Luisada, P.V. (1978) The phencyclidine psychosis: Phenomenology and treatment. In: Phencyclidine (PCP) Abuse: An Appraisal, NIDA Research Monograph 21. R.C. Peterson and R.C. Stillman, eds. U.S. Government Printing Office, Washington, D.C., pp. 241-253.
30. Maisonneuve, I.M., Keller, R.W., and Glick, S.D. (1990) Similar effects of D-amphetamine and cocaine on extracellular dopamine levels in medial prefrontal cortex of rats. Brain Res., 535:221-226.
31. Matthews, J.N.S., Altman, D.G., and Campbell, M.J. (1990) Analysis of serial measurements in medical research. Br. Med. J. [Clin. Res.], 300:230-235.
32. Maurice, T., Vignon, J., Kamenka, J.-M., and Chicheportiche, R. (1991) Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo. J. Neurochem., 56:553-559.
33. Nishijima, K., Nishikawa, T., Hashimoto, A., Umino, A., Kashiwa, A., Oka, T., and Takahashi, K. (1993) Differential effects of phencyclidine on dopamine and its metabolites in the rat medial frontal cortex and striatum: an in vivo dialysis study. Soc. Neurosci. Abstr., 19:830.
34. Nishijima, K., Kashiwa, A., and Nishikawa, T. (1994) Preferential stimulation of extracellular release of dopamine in rat frontal cortex to striatum following competitive inhibition of the N-methyl-D-aspartate receptor. J. Neurochem., 63:375-378.
35. Nishikawa, T., Umino, A., Tanii, Y., Hashimoto, A., Hata, N., Takashima, M , Takahashi, K., and Toru, M. (1991) Dysfunction of excitatory amino acidergic systems and schizophrenic disorders. In: Biological Basis of Schizophrenic Disorders. T. Nakazawa, ed. Japan Scientific Societies Press, Tokyo, and Karger, Basel, pp. 65-76.
36. Ozaki, N., Nakahara, D., Miura, H., Kasahara, Y., and Nagatsu, T. (1989) Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method. J. Neurochem., 53 1861-1864.
37. Parker, E.M., and Cubeddu, L.X. (1986) Effects of D-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum, II. Release in the presence of vesicular transmitter stores. J. Pharmacol Exp. Ther., 237:193-203.
38. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, Sydney.
39. Robinson, T.E., and Camp, D.M. (1990) Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats? Neuropsychopharmacology, 3:163-173.
40. Santiago, M., Machado, A., and Cano, J. (1993) Regulation of prefrontal cortical dopamine release by dopamine receptor agonist and antagonists. Eur. J. Pharmacol., 239:83-91.
41. Scatton, B , Glowinski, J., and Julou L. (1975) Neuroleptics: Effects on dopamine synthesis in nigro-neostriatal, mesolimbic and mesocortical dopaminergic systems. In: Antipsychotic Drugs, Pharmacodynamics and Pharmacokinetics. G. Sedvall, B. Uvenas, and I. Zotterman, eds. Pergamon, Oxford, p. 243-255.
42. Sharman, D.F. (1981) The turnover of catecholamines. In: Central Transmitter Turnover, C.J. Pycock and T.V. Taberner, eds. University Park Press, Baltimore, pp. 20-58.
43. 3H]-serotonm uptake in synaptosomal preparation from rat brain. Biochem. Pharmacol., 26:1435-1439.
44. Tanii, Y., Nishikawa, T., Umino, A., and Takahashi, K. (1990) Phencyclidine increases extracellular dopamine metabolites in rat medial frontal cortex as measured by in vivo dialysis. Neurosci. Lett., 112:318-323.
45. Umino, A., Nishikawa, T., and Takahashi, K. (1990) Effects of noncompetitive antagonists for NMDA type excitatory amino acid receptor on monoamine metabolism in rat brain. The 17th Congress of CINP, Kyoto, Abstr., p. 316.
46. Vickroy, T.W., and Johnson, KM. (1982) Similar dopamine releasing action of phencyclidine and non-amphetamine stimulants in the rat striatum. J. Pharmacol. Exp. Ther., 223:669-674.
47. Westerink, B.H.C., Tuntler, J., Damsma, G., Rollema, H., and de Vries, J.B. (1987) The use of tetrodotoxin for the characterization of drugenhanced dopamine release in conscious rats studied by brain dialysis. Naunyn Schmiedebergs Arch, Pharmacol., 336:502-507.
48. Wong, E.H.F., Kemp, J.A., Priestly, T., Knight, A.R., Woodruff, G.N., and Iversen, L.L. (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A., 83:7104-7108.
49. Yonezawa Y., Kuroki, T., Nakane, H., Tashiro, N., Hondo, H., Nakamura, K., Hirano, M., and Uchimura, H. (1995) Involvement of GABAergic systems in phencyclidine-induced dopamine release in the rat prefrontal cortex. Ann. Rep. Pharamacopsychiatr. Res. Found. (in Japanese with English abstract), 26:178-184.
50. Zetterstrom, T., Sharp, T., Collin, A.K., and Ungerstedt, U (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol., 148:327-334.